CTA Icon

We're pleased to announce the launch of our enhanced SureSeq™ CLL + CNV V3 Panel for deeper insights into CLL progression

Laboratory scientist using a telescope to identify star constellations being supported by an OGT expert.

An expanding portfolio of NGS panels for research into haematological and solid tumour cancers, as well as library preparation kits for the accurate detection of a wide range of genetic aberrations

SureSeq™ NGS panels have been designed in collaboration with recognised cancer experts to detect key aberrations implicated in a wide range of haematological and solid tumour cancers. More so, you can modify specific panels to what’s relevant to your research with SureSeq myPanel, our regularly updated, expert-curated library of pre-optimised cancer content. Simply mix and match the gene, exonic or intronic content you need to create an NGS cancer panel that meets your exact requirements.

Our unique panel design coupled with hybridisation-based enrichment offers unparalleled coverage completeness and uniformity, allowing accurate detection of low-frequency SNVs and indels, as well as structural aberrations such as ITDs, PTDs, CNVs, LOH and translocations. Combined with our various SureSeq LPK products, SureSeq alleviates the burden of running multiple assays and streamlines your research, delivering comprehensive results using a single NGS workflow.

All SureSeq panels come with Interpret, our powerful and easy-to-use NGS analysis solution providing effortless translation of all your NGS data into meaningful results.

Learn more about our custom NGS panel service
View all products

Featured SureSeq resources

View all NGS resources and support

Have a question or want to know more about our SureSeq NGS products?

Call +44 (0)1865 856800 Email contact@ogt.com Send us a message and we will get back to you